Insulin Delivery Devices Market – Global Industry Analysis and Forecast (2022-2029)


Insulin Delivery Devices Market is expected to reach US$ 35.82 Bn. at a CAGR of 9.1% during the forecast period 2029.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

Insulin Delivery Devices Market

To know about the Research Methodology :- Request Free Sample Report

Insulin delivery devices market is segmented into product type, distribution channel, and region. On the basis of product type, the market is divided into  Pumps (Tubed Pumps, Tubeless Pumps), Pens (Reusable, Disposable), Pen Needles (Standard, Safety), Syringes. Based on distribution channel, a market is classified into Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers. Geographically, a market is spread by North America, Asia-Pacific, Latin America, Europe, Middle East & Africa.

Globally, an escalating prevalence of diabetes is the prominent reason behind Insulin Delivery Devices Market expansion. Owing to inappropriate eating habits and lack of physical work; diabetes incidences are rising at alarming rates in developing countries too. From the consumer’s side, usage complication and probability of injury due to injections have been resulting in a shift from invasive devices to minimally invasive ones.

More and more minimally invasive devices are gaining demand around the globe, especially in developed nations. The insulin delivery devices market faces some peculiar challenges which have been and will continue to be hindering growth during the forecast period. Factors such as the prohibitive cost of insulin and insulin delivery devices, inconsistencies in adherence of insulin uptake and psychological resistances to self-injection due to needle-phobia are a major roadblock in Insulin Delivery Devices Market growth.

Insulin Delivery Devices Market had the highest market in 2021. The need for better diabetes management will drive demand for the insulin pumps during the forecast period. Minimally invasive nature of pumps will increasingly attract more consumers over the coming years, especially in an industrialized nation; however, their cost will prove to be a major restraining factor for the business growth.

Increasing demand for insulin-delivering devices and minimally invasive alternatives such as pumps, advancements in insulin devices in terms of design and functioning, an increasing prevalence of diabetes and ease offered by some insulin delivery devices to patients are some of the major market growth driving factors observed worldwide.

North America Insulin Delivery Devices Market accounted for the highest revenue in 2021 and is projected to grow at a significant rate during the forecast period. U.S. insulin delivery devices market accounted for the highest regional share of more than 95% in 2021. Increasing diabetes prevalence coupled with rising disposable income level will drive market growth over the forecast period. Technological advances in insulin delivery devices along with favorable government initiatives to execute better diabetes management will further fuel industry growth.

key players operating market are Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation, Ypsomed, Tandem Diabetes Care, Inc., Animas Corporation, B. Braun Melsungen AG, Johnson & Johnson,  Medtrum Technologies, Cellnova, Roche Holdings, Spring Health Solutions, Debiotech, CeQur, Valeritas Holding, Abbott Diabetes Care

The objective of the report is to present comprehensive Global Insulin Delivery Devices Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language.

The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Insulin Delivery Devices Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Insulin Delivery Devices Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Insulin Delivery Devices Market  North America for Asia Pacific make the report investor’s guide.

Insulin Delivery Devices Market Scope :Inquire before buying


Insulin Delivery Devices Market By Product Type:

• Pumps (Tubed Pumps, Tubeless Pumps)
• Pens (Reusable, Disposable)
• Pen Needles (Standard, Safety)
• Syringes

Insulin Delivery Devices Market by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Diabetes Clinics/ Centers

Insulin Delivery Devices Market By Region:

• North America
• Europe
• Asia Pacific
• Middle East &amp & Africa
• Latin America

Insulin Delivery Devices Market Key Players:

• Eli Lilly
• Sanofi
• Novo Nordisk
• Beckton and Dickenson
• Roche
• Medtronic
• Insulet Corporation
• Ypsomed
• Tandem Diabetes Care, Inc.
• Animas Corporation
• B. Braun Melsungen AG
• Johnson & Johnson
• Medtrum Technologies
• Cellnova
• Roche Holdings
• Spring Health Solutions
• Debiotech
• CeQur
• Valeritas Holding
• Abbott Diabetes Care

Frequently Asked Questions:

1. Which region has the largest share in Global Insulin Delivery Devices Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Insulin Delivery Devices Market?
Ans: The Global Insulin Delivery Devices Market is growing at a CAGR of 9.1% during forecasting period 2022-2029.

3. What is scope of the Global Insulin Delivery Devices market report?
Ans: Global Insulin Delivery Devices Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Insulin Delivery Devices market?
Ans: The important key players in the Global Insulin Delivery Devices Market are – Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation, Ypsomed, Tandem Diabetes Care, Inc., Animas Corporation, B. Braun Melsungen AG, Johnson & Johnson, Medtrum Technologies, Cellnova, Roche Holdings, Spring Health Solutions, Debiotech, CeQur, Valeritas Holding, and Abbott Diabetes Care

5. What is the study period of this market?
Ans: The Global Insulin Delivery Devices Market is studied from 2021 to 2029. 




Global Insulin Delivery Devices Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Insulin Delivery Devices Market Size, by Market Value (US$ Bn) and Market, by Region

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.3.7. Key Trends in Global Insulin Delivery Devices Market

5. Global Insulin Delivery Devices Market Analysis and Forecast
5.1. Global Insulin Delivery Devices Market Analysis and Forecast
5.2. Global Insulin Delivery Devices Market Size& Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America

6. Global Insulin Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Insulin Delivery Devices Market Value Share Analysis, by Product Type
6.4. Market Size (US$ Bn) Forecast, by Product Type
6.5. Global Insulin Delivery Devices Market Analysis, by Product Type
6.6. Insulin Delivery Devices Market Attractiveness Analysis, by Product Type

7. Global Insulin Delivery Devices Market Analysis and Forecast, by Distribution Channel
7.1. Introduction and Definition
7.2. Global Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
7.3. Market Size (US$ Bn) Forecast, by Distribution Channel
7.4. Global Insulin Delivery Devices Market Analysis, by Distribution Channel
7.5. Global Insulin Delivery Devices Market Attractiveness Analysis, by Distribution Channel

8. Global Insulin Delivery Devices Market Analysis, by Region
8.1. Global Insulin Delivery Devices Market Value Share Analysis, by Region
8.2. Market Size (US$ Bn) Forecast, by Region
8.3. Global Insulin Delivery Devices Market Attractiveness Analysis, by Region

9. North America Insulin Delivery Devices Market Analysis
9.1. Key Findings
9.2. North America Insulin Delivery Devices Market Overview
9.3. North America Insulin Delivery Devices Market Value Share Analysis, by Product Type
9.4. North America Insulin Delivery Devices Market Forecast, by Product Type
9.4.1. Pumps (Tubed Pumps, Tubeless Pumps)
9.4.2. Pens (Reusable, Disposable)
9.4.3. Pen Needles (Standard, Safety)
9.4.4. Syringes
9.5. North America Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
9.6. North America Insulin Delivery Devices Market Forecast, by Distribution Channel
9.6.1. Hospital Pharmacy
9.6.2. Retail Pharmacy
9.6.3. Online Sales
9.6.4. Diabetes Clinics/ Centers
9.7. North America Insulin Delivery Devices Market Value Share Analysis, by Country
9.8. North America Insulin Delivery Devices Market Forecast, by Country
9.8.1.1. U.S., 2021-2029
9.8.1.2. Canada, 2021-2029
9.9. North America Insulin Delivery Devices Market Analysis, by Country
9.10. U.S. Insulin Delivery Devices Market Forecast, by Product Type
9.10.1. Pumps (Tubed Pumps, Tubeless Pumps)
9.10.2. Pens (Reusable, Disposable)
9.10.3. Pen Needles (Standard, Safety)
9.10.4. Syringes
9.11. U.S. Insulin Delivery Devices Market Forecast, by Distribution Channel
9.11.1. Hospital Pharmacy
9.11.2. Retail Pharmacy
9.11.3. Online Sales
9.11.4. Diabetes Clinics/ Centers
9.12. Canada Insulin Delivery Devices Market Forecast, by Product Type
9.12.1. Pumps (Tubed Pumps, Tubeless Pumps)
9.12.2. Pens (Reusable, Disposable)
9.12.3. Pen Needles (Standard, Safety)
9.12.4. Syringes
9.13. Canada Insulin Delivery Devices Market Forecast, by Distribution Channel
9.13.1. Hospital Pharmacy
9.13.2. Retail Pharmacy
9.13.3. Online Sales
9.13.4. Diabetes Clinics/ Centers
9.14. North America Insulin Delivery Devices Market Attractiveness Analysis
9.14.1. By Product Type
9.14.2. By Distribution Channel
9.15. PEST Analysis

10. Europe Insulin Delivery Devices Market Analysis
10.1. Key Findings
10.2. Europe Insulin Delivery Devices Market Overview
10.3. Europe Insulin Delivery Devices Market Value Share Analysis, by Product Type
10.4. Europe Insulin Delivery Devices Market Forecast, by Product Type
10.4.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.4.2. Pens (Reusable, Disposable)
10.4.3. Pen Needles (Standard, Safety)
10.4.4. Syringes
10.5. Europe Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
10.6. Europe Insulin Delivery Devices Market Forecast, by Distribution Channel
10.6.1. Hospital Pharmacy
10.6.2. Retail Pharmacy
10.6.3. Online Sales
10.6.4. Diabetes Clinics/ Centers
10.7. Europe Insulin Delivery Devices Market Value Share Analysis, by Country
10.8. Europe Insulin Delivery Devices Market Forecast, by Country
10.8.1.1. Germany
10.8.1.2. U.K.
10.8.1.3. France
10.8.1.4. Italy
10.8.1.5. Spain
10.8.1.6. Rest of Europe
10.9. Europe Insulin Delivery Devices Market Analysis, by Country/ Sub-region
10.10. Germany Insulin Delivery Devices Market Forecast, by Product Type
10.10.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.10.2. Pens (Reusable, Disposable)
10.10.3. Pen Needles (Standard, Safety)
10.10.4. Syringes
10.11. Germany Insulin Delivery Devices Market Forecast, by Distribution Channel
10.11.1. Hospital Pharmacy
10.11.2. Retail Pharmacy
10.11.3. Online Sales
10.11.4. Diabetes Clinics/ Centers
10.12. U.K. Insulin Delivery Devices Market Forecast, by Product Type
10.12.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.12.2. Pens (Reusable, Disposable)
10.12.3. Pen Needles (Standard, Safety)
10.12.4. Syringes
10.13. U.K. Insulin Delivery Devices Market Forecast, by Distribution Channel
10.13.1. Hospital Pharmacy
10.13.2. Retail Pharmacy
10.13.3. Online Sales
10.13.4. Diabetes Clinics/ Centers
10.14. France Insulin Delivery Devices Market Forecast, by Product Type
10.14.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.14.2. Pens (Reusable, Disposable)
10.14.3. Pen Needles (Standard, Safety)
10.14.4. Syringes
10.15. France Insulin Delivery Devices Market Forecast, by Distribution Channel
10.15.1. Hospital Pharmacy
10.15.2. Retail Pharmacy
10.15.3. Online Sales
10.15.4. Diabetes Clinics/ Centers
10.16. Italy Insulin Delivery Devices Market Forecast, by Product Type
10.16.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.16.2. Pens (Reusable, Disposable)
10.16.3. Pen Needles (Standard, Safety)
10.16.4. Syringes
10.17. Italy Insulin Delivery Devices Market Forecast, by Distribution Channel
10.17.1. Hospital Pharmacy
10.17.2. Retail Pharmacy
10.17.3. Online Sales
10.17.4. Diabetes Clinics/ Centers
10.18. Spain Insulin Delivery Devices Market Forecast, by Product Type
10.18.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.18.2. Pens (Reusable, Disposable)
10.18.3. Pen Needles (Standard, Safety)
10.18.4. Syringes
10.19. Spain Insulin Delivery Devices Market Forecast, by Distribution Channel
10.19.1. Hospital Pharmacy
10.19.2. Retail Pharmacy
10.19.3. Online Sales
10.19.4. Diabetes Clinics/ Centers
10.20. Rest of Europe Insulin Delivery Devices Market Forecast, by Product Type
10.20.1. Pumps (Tubed Pumps, Tubeless Pumps)
10.20.2. Pens (Reusable, Disposable)
10.20.3. Pen Needles (Standard, Safety)
10.20.4. Syringes
10.21. Rest of Europe Insulin Delivery Devices Market Forecast, by Distribution Channel
10.21.1. Hospital Pharmacy
10.21.2. Retail Pharmacy
10.21.3. Online Sales
10.21.4. Diabetes Clinics/ Centers
10.22. Europe Insulin Delivery Devices Market Attractiveness Analysis
10.22.1. By Product Type
10.22.2. By Distribution Channel
10.23. PEST Analysis

11. Asia Pacific Insulin Delivery Devices Market Analysis
11.1. Key Findings
11.2. Asia Pacific Insulin Delivery Devices Market Overview
11.3. Asia Pacific Insulin Delivery Devices Market Value Share Analysis, by Product Type
11.4. Asia Pacific Insulin Delivery Devices Market Forecast, by Product Type
11.4.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.4.2. Pens (Reusable, Disposable)
11.4.3. Pen Needles (Standard, Safety)
11.4.4. Syringes
11.5. Asia Pacific Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Insulin Delivery Devices Market Forecast, by Distribution Channel
11.6.1. Hospital Pharmacy
11.6.2. Retail Pharmacy
11.6.3. Online Sales
11.6.4. Diabetes Clinics/ Centers
11.7. Asia Pacific Insulin Delivery Devices Market Value Share Analysis, by Country
11.8. Asia Pacific Insulin Delivery Devices Market Forecast, by Country
11.8.1. China, 2021-2029
11.8.2. India, 2021-2029
11.8.3. Japan, 2021-2029
11.8.4. ASEAN, 2021-2029
11.8.5. Rest of Asia Pacific, 2021-2029
11.9. Asia Pacific Insulin Delivery Devices Market Analysis, by Country/ Sub-region
11.10. China Insulin Delivery Devices Market Forecast, by Product Type
11.10.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.10.2. Pens (Reusable, Disposable)
11.10.3. Pen Needles (Standard, Safety)
11.10.4. Syringes
11.11. China Insulin Delivery Devices Market Forecast, by Distribution Channel
11.11.1. Hospital Pharmacy
11.11.2. Retail Pharmacy
11.11.3. Online Sales
11.11.4. Diabetes Clinics/ Centers
11.12. India Insulin Delivery Devices Market Forecast, by Product Type
11.12.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.12.2. Pens (Reusable, Disposable)
11.12.3. Pen Needles (Standard, Safety)
11.12.4. Syringes
11.13. India Insulin Delivery Devices Market Forecast, by Distribution Channel
11.13.1. Hospital Pharmacy
11.13.2. Retail Pharmacy
11.13.3. Online Sales
11.13.4. Diabetes Clinics/ Centers
11.14. Japan Insulin Delivery Devices Market Forecast, by Product Type
11.14.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.14.2. Pens (Reusable, Disposable)
11.14.3. Pen Needles (Standard, Safety)
11.14.4. Syringes
11.15. Japan Insulin Delivery Devices Market Forecast, by Distribution Channel
11.15.1. Hospital Pharmacy
11.15.2. Retail Pharmacy
11.15.3. Online Sales
11.15.4. Diabetes Clinics/ Centers
11.16. ASEAN Insulin Delivery Devices Market Forecast, by Product Type
11.16.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.16.2. Pens (Reusable, Disposable)
11.16.3. Pen Needles (Standard, Safety)
11.16.4. Syringes
11.17. ASEAN Insulin Delivery Devices Market Forecast, by Distribution Channel
11.17.1. Hospital Pharmacy
11.17.2. Retail Pharmacy
11.17.3. Online Sales
11.17.4. Diabetes Clinics/ Centers
11.18. Rest of Asia Pacific Insulin Delivery Devices Market Forecast, by Product Type
11.18.1. Pumps (Tubed Pumps, Tubeless Pumps)
11.18.2. Pens (Reusable, Disposable)
11.18.3. Pen Needles (Standard, Safety)
11.18.4. Syringes
11.19. Rest of Asia Pacific Insulin Delivery Devices Market Forecast, by Distribution Channel
11.19.1. Hospital Pharmacy
11.19.2. Retail Pharmacy
11.19.3. Online Sales
11.19.4. Diabetes Clinics/ Centers
11.20. Asia Pacific Insulin Delivery Devices Market Attractiveness Analysis
11.20.1. By Product Type
11.20.2. By Distribution Channel
11.21. PEST Analysis

12. Middle East & Africa Insulin Delivery Devices Market Analysis
12.1. Key Findings
12.2. Middle East & Africa Insulin Delivery Devices Market Overview
12.3. Middle East & Africa Insulin Delivery Devices Market Value Share Analysis, by Product Type
12.4. Middle East & Africa Insulin Delivery Devices Market Forecast, by Product Type
12.4.1. Pumps (Tubed Pumps, Tubeless Pumps)
12.4.2. Pens (Reusable, Disposable)
12.4.3. Pen Needles (Standard, Safety)
12.4.4. Syringes
12.5. Middle East & Africa Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
12.6. Middle East & Africa Insulin Delivery Devices Market Forecast, by Distribution Channel
12.6.1. Hospital Pharmacy
12.6.2. Retail Pharmacy
12.6.3. Online Sales
12.6.4. Diabetes Clinics/ Centers
12.7. Middle East & Africa Insulin Delivery Devices Market Value Share Analysis, by Country
12.8. Middle East & Africa Insulin Delivery Devices Market Forecast, by Country
12.8.1. GCC, 2021-2029
12.8.2. South Africa, 2021-2029
12.8.3. Rest of Middle East & Africa, 2021-2029
12.9. Middle East & Africa Insulin Delivery Devices Market Analysis, by Country/ Sub-region
12.10. GCC Insulin Delivery Devices Market Forecast, by Product Type
12.10.1. Pumps (Tubed Pumps, Tubeless Pumps)
12.10.2. Pens (Reusable, Disposable)
12.10.3. Pen Needles (Standard, Safety)
12.10.4. Syringes
12.11. GCC Insulin Delivery Devices Market Forecast, by Distribution Channel
12.11.1. Hospital Pharmacy
12.11.2. Retail Pharmacy
12.11.3. Online Sales
12.11.4. Diabetes Clinics/ Centers
12.12. South Africa Insulin Delivery Devices Market Forecast, by Product Type
12.12.1. Pumps (Tubed Pumps, Tubeless Pumps)
12.12.2. Pens (Reusable, Disposable)
12.12.3. Pen Needles (Standard, Safety)
12.12.4. Syringes
12.13. South Africa Insulin Delivery Devices Market Forecast, by Distribution Channel
12.13.1. Hospital Pharmacy
12.13.2. Retail Pharmacy
12.13.3. Online Sales
12.13.4. Diabetes Clinics/ Centers
12.14. Rest of Middle East & Africa Insulin Delivery Devices Market Forecast, by Product Type
12.14.1. Pumps (Tubed Pumps, Tubeless Pumps)
12.14.2. Pens (Reusable, Disposable)
12.14.3. Pen Needles (Standard, Safety)
12.14.4. Syringes
12.15. Rest of Middle East & Africa Insulin Delivery Devices Market Forecast, by Distribution Channel
12.15.1. Hospital Pharmacy
12.15.2. Retail Pharmacy
12.15.3. Online Sales
12.15.4. Diabetes Clinics/ Centers
12.16. Middle East & Africa Insulin Delivery Devices Market Attractiveness Analysis
12.16.1. By Product Type
12.16.2. By Distribution Channel
12.17. PEST Analysis

13. Latin America Insulin Delivery Devices Market Analysis
13.1. Key Findings
13.2. Latin America Insulin Delivery Devices Market Overview
13.3. Latin America Insulin Delivery Devices Market Value Share Analysis, by Product Type
13.4. Latin America Insulin Delivery Devices Market Forecast, by Product Type
13.4.1. Pumps (Tubed Pumps, Tubeless Pumps)
13.4.2. Pens (Reusable, Disposable)
13.4.3. Pen Needles (Standard, Safety)
13.4.4. Syringes
13.5. Latin America Insulin Delivery Devices Market Value Share Analysis, by Distribution Channel
13.6. Latin America Insulin Delivery Devices Market Forecast, by Distribution Channel
13.6.1. Hospital Pharmacy
13.6.2. Retail Pharmacy
13.6.3. Online Sales
13.6.4. Diabetes Clinics/ Centers
13.7. Latin America Insulin Delivery Devices Market Value Share Analysis, by Country
13.8. Latin America Insulin Delivery Devices Market Forecast, by Country
13.8.1.1. Brazil, 2021-2029
13.8.1.2. Mexico, 2021-2029
13.8.1.3. Rest of Latin America, 2021-2029
13.9. Latin America Insulin Delivery Devices Market Analysis, by Country/ Sub-region
13.10. Brazil Insulin Delivery Devices Market Forecast, by Product Type
13.10.1. Pumps (Tubed Pumps, Tubeless Pumps)
13.10.2. Pens (Reusable, Disposable)
13.10.3. Pen Needles (Standard, Safety)
13.10.4. Syringes
13.11. Brazil Insulin Delivery Devices Market Forecast, by Distribution Channel
13.11.1. Hospital Pharmacy
13.11.2. Retail Pharmacy
13.11.3. Online Sales
13.11.4. Diabetes Clinics/ Centers
13.12. Mexico Insulin Delivery Devices Market Forecast, by Product Type
13.12.1. Pumps (Tubed Pumps, Tubeless Pumps)
13.12.2. Pens (Reusable, Disposable)
13.12.3. Pen Needles (Standard, Safety)
13.12.4. Syringes
13.13. Mexico Insulin Delivery Devices Market Forecast, by Distribution Channel
13.13.1. Hospital Pharmacy
13.13.2. Retail Pharmacy
13.13.3. Online Sales
13.13.4. Diabetes Clinics/ Centers
13.14. Rest of Latin America Insulin Delivery Devices Market Forecast, by Product Type
13.14.1. Pumps (Tubed Pumps, Tubeless Pumps)
13.14.2. Pens (Reusable, Disposable)
13.14.3. Pen Needles (Standard, Safety)
13.14.4. Syringes
13.15. Rest of Latin America Insulin Delivery Devices Market Forecast, by Distribution Channel
13.15.1. Hospital Pharmacy
13.15.2. Retail Pharmacy
13.15.3. Online Sales
13.15.4. Diabetes Clinics/ Centers
13.16. Latin America Insulin Delivery Devices Market Attractiveness Analysis
13.16.1. By Product Type
13.16.2. By Distribution Channel
13.17. PEST Analysis

14. Company Profiles
14.1. Market Share Analysis, by Company
14.2. Competition Matrix
14.3. Company Profiles: Key Players
14.3.1. Eli Lilly
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Business Strategy
14.3.1.4. Recent Developments
14.3.1.5. Manufacturing Footprint
14.3.2. Sanofi
14.3.3. Novo Nordisk
14.3.4. Beckton and Dickenson
14.3.5. Roche
14.3.6. Medtronic
14.3.7. Insulet Corporation
14.3.8. Ypsomed
14.3.9. Tandem Diabetes Care, Inc.
14.3.10. Animas Corporation
14.3.11. B. Braun Melsungen AG
14.3.12. Johnson & Johnson
14.3.13. Medtrum Technologies
14.3.14. Cellnova
14.3.15. Roche Holdings
14.3.16. Spring Health Solutions
14.3.17. Debiotech
14.3.18. CeQur
14.3.19. Valeritas Holding
14.3.20. Abbott Diabetes Care
15. Primary Key Insights
  • INQUIRE BEFORE BUYING